Beedan 50 mg Tablet
  1. Home
  2. Pharma Products
  3. Adley formulatins
  4. Beedan 50 mg Tablet

Beedan 50 mg Tablet

Beedan 50 mg Tablet contains dasatinib, a targeted anticancer medicine used to treat certain blood cancers. Each tablet contains 50 mg of dasatinib and is taken orally as prescribed by a specialist. It is mainly used for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

BUY NOW

Category

Dasatinib is a tyrosine kinase inhibitor that blocks abnormal proteins responsible for signaling leukemia cells to grow and survive. By inhibiting BCR-ABL and related tyrosine kinases, it helps slow the progression of certain leukemia cells. Treatment is given according to an individualized oncology protocol based on the patient’s disease and response to therapy. Regular blood tests and clinical monitoring are important during treatment to assess response and manage potential adverse effects.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer/Marketer Adley Formulations

Product Also Known As

Beedan 50 mg Tablet, Dasatinib 50 mg Tablet, Beedan Dasatinib Tablet, Dasatinib Anticancer Tablet, Beedan Leukemia Treatment Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet